Pulmatrix (PULM) Price to FCF (2014 - 2026)
Pulmatrix's (PULM) quarterly Price to FCF came in at 5.61 in Q2 2026, up 58.05% year-over-year from 3.55 in Q2 2025, and down 27.14% quarter-over-quarter from 4.42 in Q1 2026.
Analysis
Pulmatrix (PULM) Price to FCF (2014 - 2026) Analysis & Trends
Pulmatrix has disclosed Price to FCF across 13 years of filings, most recently posting 5.61 for Q2 2026.
- In Q2 2026, Price to FCF rose 58.05% year-over-year to 5.61; the TTM figure through Jun 2026 stood at 1.59 (up 49.57% YoY), while the FY2025 annual figure was 1.5, up 34.49% from the prior year.
- Price to FCF came in at 5.61 for Q2 2026 at Pulmatrix, down from 4.42 in the prior quarter.
- In the past five years, Price to FCF ranged from a high of 1.63 in Q2 2023 to a low of 20.22 in Q4 2024.
- Average Price to FCF over 5 years is 6.38, with a median of 3.45 recorded in 2022.
- Year-over-year, Price to FCF surged 73.11% in 2022 and plunged 627.37% in 2025.
- Over 5 years, Price to FCF stood at 2.82 in 2022, then fell by 19.08% to 3.36 in 2023, then plunged by 502.04% to 20.22 in 2024, then jumped by 42.94% to 11.54 in 2025, then soared by 51.34% to 5.61 in 2026.
- Per Business Quant data, the three most recent Price to FCF figures were 5.61 in Q2 2026, 4.42 in Q1 2026, and 11.54 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.24 Bn | 620.48 Bn | 17.26 Bn |
| 2 | AbbVie | 446.48 Bn | 439.91 Bn | 12.70 Bn |
| 3 | Merck | 356.77 Bn | 349.63 Bn | 12.21 Bn |
| 4 | Novartis Ag | 269.07 Bn | 261.38 Bn | 11.24 Bn |
| 5 | Pfizer | 156.47 Bn | 144.77 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.75 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.09 Bn | 43.09 Bn | - |
| 8 | Incyte | 24.99 Bn | 20.45 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.29 Bn | 18.63 Bn | 683.80 Mn |
| 10 | Pulmatrix | 5.19 Mn | 5.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.61 |
| Mar 31, 2026 | -4.42 |
| Dec 31, 2025 | -11.54 |
| Sep 30, 2025 | -17.22 |
| Jun 30, 2025 | -13.38 |
| Mar 31, 2025 | -13.51 |
| Dec 31, 2024 | -20.22 |
| Sep 30, 2024 | -2.56 |
| Jun 30, 2024 | -1.84 |
| Mar 31, 2024 | -2.16 |
| Dec 31, 2023 | -3.36 |
| Sep 30, 2023 | -2.31 |
| Jun 30, 2023 | -1.63 |
| Mar 31, 2023 | -1.96 |
| Dec 31, 2022 | -2.82 |
| Sep 30, 2022 | -3.55 |
| Jun 30, 2022 | -3.16 |
| Mar 31, 2022 | -3.67 |
| Dec 31, 2021 | -6.38 |
| Sep 30, 2021 | -13.19 |